[Intensive glucose control in type 2 diabetes. The benefit greater than the risks?].
Rydén
Mikael
M
Kliniken för endokrinologi, diabetes och metabolism, Karolinska Universitetssjukhuset Huddinge, Stockholm. mikael.ryden@ki.se
Freyschuss
Bo
B
D001786:Blood Glucose / Q000032:analysis*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D003925:Diabetic Angiopathies / Q000517:prevention & control; D019317:Evidence-Based Medicine; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; C517652:hemoglobin A1c protein, human